Back to User profile » Dr Richard Stanford
Papers published by Dr Richard Stanford:
Racial and Socioeconomic Differences in Real-World Use of Biologic Therapy for Asthma
Littlejohn M, Zuckerman AD, Gargurevich N, Choi L, Lubwama R, Stanford RH, Campbell C, Nunez M, Petruski-Ivleva N, Tardy AL, Cruchelow K
Journal of Asthma and Allergy 2026, 19:587574
Published Date: 5 June 2026
Characterization of Patients with COPD and GOLD E Classification in the United States
Bhatt SP, Zhang Y, White J, Stanford RH, Mayen Herrera E, Cunoosamy D, Djandji M, Soliman M, Qureshi T, Subramaniam A
International Journal of Chronic Obstructive Pulmonary Disease 2026, 21:598962
Published Date: 19 March 2026
Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations
Fuoco MJ, Mularski RA, Wu B, Moretz C, McBurnie MA, Stanford RH, Crawford P, Gratie D, Salas B
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2755-2767
Published Date: 7 October 2021
Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol
Moretz C, Bengtson LGS, Sharpsten L, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2047-2060
Published Date: 4 September 2019
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study
Moretz C, Sharpsten L, Bengtson LGS, Koep E, Le L, Tong J, Stanford RH, Hahn B, Ray R
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1721-1737
Published Date: 1 August 2019
Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:343-352
Published Date: 19 February 2019
The impact of patient education and shared decision making on hospital readmissions for COPD
Collinsworth AW, Brown RM, James CS, Stanford RH, Alemayehu D, Priest EL
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1325-1332
Published Date: 24 April 2018
Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model
Wilson MR, Patel JG, Coleman A, McDade CL, Stanford RH, Earnshaw SR
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:997-1008
Published Date: 24 March 2017
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
Stanford RH, Shah M, D'Souza AO
Journal of Asthma and Allergy 2013, 6:1-10
Published Date: 28 December 2012